Abstract
Dear Editor, The paper by Addolorato et al . (2011) attributes to me and to Dr William Bucknam a hypothesis that neither of us has advanced. Addolorato et al . write: ‘However, anecdotal reports have hypothesized the ability of high doses of baclofen (up to 140 and 270 mg/day) to reduce alcohol craving and consumption (Ameisen, 2005a; Bucknam, 2007)’. My 2005 paper and Bucknam's (2007) paper expressly advance a very different hypothesis, that baclofen at higher doses can suppress , …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
